• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Break (1069); Detachment Of Device Component (1104)
Patient Problems No Known Impact Or Consequence To Patient (2692); Device Embedded In Tissue or Plaque (3165)
Event Type  malfunction  
Event Description
This spontaneous case was reported by a physician and describes the occurrence of device breakage ("detachment difficulty; micro-insert breakage") in a female patient who had essure (batch no.He0136l) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.On (b)(6) 2018, the patient had essure inserted.On an unknown date, the patient experienced device breakage (seriousness criterion medically significant) and complication of device insertion ("detachment difficulty; micro-insert breakage").At the time of the report, the device breakage and complication of device insertion outcome was unknown.The reporter provided no causality assessment for complication of device insertion and device breakage with essure.Incident at the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
This spontaneous case was reported by a physician and describes the occurrence of device breakage ("detachment difficulty;micro-insert breakage") in a female patient who had essure (batch no.He0136l) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.On (b)(6) 2018, the patient had essure inserted.On an unknown date, the patient experienced device breakage (seriousness criterion medically significant) and complication of device insertion ("detachment difficulty;micro-insert breakage").At the time of the report, the device breakage and complication of device insertion outcome was unknown.The reporter provided no causality assessment for complication of device insertion and device breakage with essure.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 16-mar-2018: quality-safety evaluation of ptc.Incident at the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
This spontaneous case was reported by a physician and describes the occurrence of device breakage ("detachment difficulty; micro-insert breakage") in a female patient who had essure (batch no.He0136l) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.On (b)(6) 2018, the patient had essure inserted.On an unknown date, the patient experienced device breakage (seriousness criterion medically significant) and complication of device insertion ("detachment difficulty; micro-insert breakage").At the time of the report, the device breakage and complication of device insertion outcome was unknown.The reporter provided no causality assessment for complication of device insertion and device breakage with essure.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 11-jan-2019: quality safety evaluation of ptc.Incident: we received a lot number in this case.A technical investigation will be conducted, including a batch review, and a review of complaint records and other non-conformances data; should any new and reportable information become available as a result, this will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
MDR Report Key7303308
MDR Text Key101565368
Report Number2951250-2018-00956
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 01/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/28/2020
Device Model NumberESS305
Device Lot NumberHE0136L
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-